ArticleBiomedicines2026

Real World Data of Laboratory Changes and Immunophenotyping in Patients with Multiple Sclerosis Treated with Ofatumumab-Single Center Experience.

Ružica Gudelj Zorić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.